Exeala Healthcare Industries Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.30 M
- Company Age 4 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.00 M
- Revenue Growth 145.07%
- Profit Growth 164.43%
- Ebitda 110.07%
- Net Worth 224.93%
- Total Assets 6.98%
About Exeala Healthcare Industries
Exeala Healthcare Industries Private Limited (EHIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 11 May 2020 (Four years and eight months 22 days old ). Its registered office is in Thrissur, Kerala, India.
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹9.00 M.
Sathyavan Karthika and Libu serve as directors at the Company.
Company Details
-
Location
Thrissur, Kerala, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U36900KL2020PTC062055
-
Company No.
062055
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 May 2020
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Exeala Healthcare Industries?
Board Members (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sathyavan Karthika | Director | 04-May-2024 | Current |
Libu | Director | 12-May-2020 | Current |
Financial Performance of Exeala Healthcare Industries.
Exeala Healthcare Industries Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 145.07% increase. The company also saw a substantial improvement in profitability, with a 164.43% increase in profit. The company's net worth Soared by an impressive increase of 224.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Exeala Healthcare Industries?
In 2022, Exeala Healthcare Industries had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹9.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.90 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
27 Oct 2020 | Axis Bank Limited | ₹9.00 M | Open |
How Many Employees Work at Exeala Healthcare Industries?
Exeala Healthcare Industries has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Exeala Healthcare Industries, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exeala Healthcare Industries's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.